Submit Deal

ALGENEX

Summary

Algenex is a Spanish biotech company, backed by Cleon Capital and Columbus Venture, developing disruptive baculovirus-based technologies for the production of recombinant biologics.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

José Escribano
Founder

Sort

10 Oct 2022|Spain|Biotechnology

Target: ALGENEX

Bidder: INSUD PHARMA SLU

5 Service Providers

2 Target | 1 Bidder | 2 Vendor

7 Dealmakers

4 Target | 1 Bidder | 2 Vendor

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy